Stay updated on Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial
Sign up to get notified when there's something new on the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page.

Latest updates to the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page
- Check5 days agoChange DetectedThe page has been updated to reflect a new version of the study, with a focus on the Glooko mobile insulin dosing system for insulin degludec titration in patients with Type 2 Diabetes Mellitus. Key details about the study's design and inclusion criteria have been revised, indicating a shift in the study's focus and methodology.SummaryDifference25%
- Check13 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check56 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check71 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1.0%
- Check78 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page.